Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumour Response,”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01576666
What this trial is testing

Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumors

Who this might be right for
Dose EscalationSafetyPreliminary Efficacy+9 more
Novartis Pharmaceuticals 120
Testing effectiveness (Phase 2)Study completedNCT03702231
What this trial is testing

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
Safety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Not applicableEnded earlyNCT00589095
What this trial is testing

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities

Who this might be right for
Glioblastoma Multiforme
Yale University 5
Not applicableStudy completedNCT03546569
What this trial is testing

Tumor Cells, Tumor DNA and Immunological Response in Colonic Stent Placement

Who this might be right for
Cancer of Colon
Zealand University Hospital 20
Large-scale testing (Phase 3)UnknownNCT01048970
What this trial is testing

Effect on the Nutritional and Inflammatory Status of Docosahexaenoic Acid (DHA) and Eicosapentaenoic Acid (EPA)- Containing Supplement in Patients With Advanced Lung Cancer

Who this might be right for
Lung Cancer
National Institute of Cancerología 120
Testing effectiveness (Phase 2)UnknownNCT04006041
What this trial is testing

Combination of Toripalimab and Neoadjuvant Chemoradiotherapy in Esophageal Cancer

Who this might be right for
Esophageal Squamous Cell Carcinoma by AJCC V8 StageResectable Esophageal Cancer
Jianhua Fu 44
Large-scale testing (Phase 3)Study completedNCT01815853
What this trial is testing

Neoadjuvant Chemoradiotherapy vs. Chemotherapy Followed by Radical Gastrectomy and Adjuvant Chemotherapy for Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Sun Yat-sen University 620
Testing effectiveness (Phase 2)Study completedNCT00807573
What this trial is testing

Paclitaxel, Bevacizumab and Pemetrexed in Patients With Untreated, Advanced Non-Small Cell Lung Cancer Using Web-Based Data Collection, Patient Self-Reporting of Adverse Effects and Automated Response Assessment

Who this might be right for
Lung Cancer
Memorial Sloan Kettering Cancer Center 44
Not applicableUnknownNCT04869956
What this trial is testing

Gut Microbiome Modification Through Dietary Intervention in Patients With Colorectal Cancer: Response to Surgery

Who this might be right for
Colorectal Cancer
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia 50
Early research (Phase 1)Study completedNCT01972737
What this trial is testing

Phase I Study of Ad5-hGCC (Human Guanylyl Cyclase C)-PADRE in Stage I/II Colon Cancer

Who this might be right for
Colon Cancer
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 10
Early research (Phase 1)Study completedNCT01618357
What this trial is testing

Pre-Operative Radiation and Veliparib for Breast Cancer

Who this might be right for
Breast Cancer
Richard Zellars 19
Testing effectiveness (Phase 2)Study completedNCT03643107
What this trial is testing

Irofulven in AR-targeted and Docetaxel-Pretreated mCRPC Patients With Drug Response Predictor (DRP®)

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer Patients
Allarity Therapeutics 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT05354557
What this trial is testing

Study of Iberdomide in People With Multiple Myeloma Who Have Had an Autologous Hematopoietic Stem Cell Transplant (AHCT)

Who this might be right for
Multiple Myeloma
Memorial Sloan Kettering Cancer Center 16
Early research (Phase 1)Ended earlyNCT05096234
What this trial is testing

18F-F-AraG PET Imaging to Evaluate Immunological Response to CAR T Cell Therapy in Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Stanford University 2
Testing effectiveness (Phase 2)Study completedNCT05282901
What this trial is testing

Efficacy and Safety of Pembrolizumab in Combination With Lenvatinib in Metastatic Uveal MElanoma Patients (PLUME)

Who this might be right for
Metastatic Uveal Melanoma
Institut Curie 51
Not applicableLooking for participantsNCT06694181
What this trial is testing

Safe and Explainable AI

Who this might be right for
Artifical InteligenceCardiologyBreast Cancer+1 more
Abramson Cancer Center at Penn Medicine 300,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06851169
What this trial is testing

This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response

Who this might be right for
Non Small Cell Lung Cancer
Tang-Du Hospital 58
Not applicableActive Not RecruitingNCT03876951
What this trial is testing

Evaluation of the Accuracy of Percutaneous Biopsy by Vacuum-assisted Biopsy (VAB) to Assess Pathological Complete Response in Patients With Clinical and Radiological Complete Response After Neoadjuvant Chemotherapy (NeoVAB)

Who this might be right for
Vacuum-assisted Biopsy
Centre Georges Francois Leclerc 67
Testing effectiveness (Phase 2)Looking for participantsNCT05563766
What this trial is testing

A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer

Who this might be right for
Esophageal AdenocarcinomaEsophageal Squamous Cell CarcinomaGastroesophageal Junction Carcinoma
VA Office of Research and Development 78
Not applicableStudy completedNCT02441322
What this trial is testing

Evaluating Therapeutic Response to Novo-TTF

Who this might be right for
Glioblastoma Multiforme
Abramson Cancer Center at Penn Medicine 30
Next Page